A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

Study Number
4679825
Phase
I
Age Group
Adult
Principal Investigator
Emese Zsiros
Purpose

This is an open-label, multicenter phase 1 study to evaluate the safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0505 in Adult Participants with Advanced Solid Tumors

Check your eligibility for this trial
Check now
Full Title

A Phase I First-In-Human, Open-Label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0505 in Adult Participants with Advanced Solid Tumors

ClinicalTrials.Gov ID
NCT06792552

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355) or e-mail askroswell@roswellpark.org.